Top 10 Pharmaceutical Stocks with Highest Return on Equity: DEPO, KUN, BSTC, AKRX, NVO, TRMS, LLY, AZN, GSK, BMRN (Sep 05, 2011)

Below are the top 10 Pharmaceutical stocks with highest Return on Equity (ROE)
ratio for the last 12 months. ROE shows a companys efficiency in making profits
from shareholders equity. It is equal to net profits divided by shareholders
equity. One Chinese company (KUN) is on the list. DepoMed, Inc. (NASDAQ:DEPO)
has the 1st highest Return on Equity in this segment of the market. Its ROE was
134.78% for the last 12 months. Its net profit margin was 66.57% for the same
period. China Shenghuo Pharmaceutical Hldg, Inc. (AMEX:KUN) has the 2nd highest
Return on Equity in this segment of the market. Its ROE was 95.14% for the last
12 months. Its net profit margin was 3.94% for the same period. BioSpecifics
Technologies Corp. (NASDAQ:BSTC) has the 3rd highest Return on Equity in this
segment of the market. Its ROE was 59.39% for the last 12 months. Its net profit
margin was 65.64% for the same period. Akorn, Inc. (NASDAQ:AKRX) has the 4th
highest Return on Equity in this segment of the market. Its ROE was 53.39% for
the last 12 months. Its net profit margin was 49.85% for the same period. Novo
Nordisk A/S (ADR) (NYSE:NVO) has the 5th highest Return on Equity in this
segment of the market. Its ROE was 43.65% for the last 12 months. Its net profit
margin was 24.31% for the same period. Trimeris, Inc. (NASDAQ:TRMS) has the 6th
highest Return on Equity in this segment of the market. Its ROE was 41.35% for
the last 12 months. Its net profit margin was 75.04% for the same period. Eli
Lilly & Co. (NYSE:LLY) has the 7th highest Return on Equity in this segment of
the market. Its ROE was 38.55% for the last 12 months. Its net profit margin was
19.74% for the same period. AstraZeneca plc (ADR) (NYSE:AZN) has the 8th highest
Return on Equity in this segment of the market. Its ROE was 37.99% for the last
12 months. Its net profit margin was 24.91% for the same period. GlaxoSmithKline
plc (ADR) (NYSE:GSK) has the 9th highest Return on Equity in this segment of the
market. Its ROE was 37.01% for the last 12 months. Its net profit margin was
12.60% for the same period. BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) has the
10th highest Return on Equity in this segment of the market. Its ROE was 35.74%
for the last 12 months. Its net profit margin was 46.66% for the same period.